AI assistant
Sending…
Moderna, Inc. — Director's Dealing 2024
May 7, 2024
30610_dirs_2024-05-07_cfab884b-7cf5-475f-99b6-f060e8ebfd04.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2024-05-03
Reporting Person: Berenson Stephen (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-03 | Common Stock | M | 732 | — | Acquired | 22203 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-03 | Restricted Stock Units | $ | M | 732 | Disposed | Common Stock (732) | Direct | |
| 2024-05-06 | Stock Option (Right to Buy) | $122.13 | A | 7557 | Acquired | 2034-05-06 | Common Stock (7557) | Direct |
Footnotes
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: The shares subject to this restricted stock unit award vested in full on May 3, 2024.
F3: This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
More from Moderna, Inc.
Board/Management Information
2026
Jul 8
Call Transcript
2026
Jun 9
Call Transcript
2026
Jun 2
Call Transcript
2026
May 28
Call Transcript
2026
May 19
Call Transcript
2026
May 12
Declaration of Voting Results & Voting Rights Announcements
2026
May 11
Call Transcript
2026
May 6
Call Transcript
2026
May 1
Call Transcript
2026
Mar 10